Epigenetic Targeting of Platinum Resistant Testicular Cancer

dc.contributor.authorSonnenburg, Daniel
dc.contributor.authorSpinella, Michael J.
dc.contributor.authorAlbany, Costantine
dc.contributor.departmentDepartment of Medicine, Indiana University School of Medicineen_US
dc.date.accessioned2019-09-19T15:28:03Z
dc.date.available2019-09-19T15:28:03Z
dc.date.issued2016
dc.description.abstractThe involvement of epigenetic aberrations in the development and progression of tumors is now well established. However, little is known of the epigenetic alterations in testicular cancer and particularly in platinum refractory germ cell tumors. Germ cell derived testicular cancers, as compared to somatic tumors, appear to have a unique epigenetic profile that features more extensive DNA hypomethylation. Emerging data from clinical specimens suggest that epigenetic aberrations, especially DNA hypermethylation, can contribute to chemotherapy resistance and poor clinical outcomes in testicular germ cell tumors. Recent data indicate that testicular cancer cells, even those resistant to platinum, are highly sensitive to low doses of demethylating agents. Based on these promising preclinical studies, we suggest that DNA methylation inhibitors in combination with chemotherapeutic agents may offer a path to overcome acquired drug resistance in testicular cancer, laying the foundation and rationale for testing this class of epigenetic drugs in the clinical setting. In this mini-review we provide a brief overview of the promise of DNA methylation therapy to treat patients with refractory cancer of the testes.en_US
dc.eprint.versionAuthor's manuscripten_US
dc.identifier.citationSonnenburg, D., Spinella, M. J., & Albany, C. (2016). Epigenetic Targeting of Platinum Resistant Testicular Cancer. Current cancer drug targets, 16(9), 789–795.en_US
dc.identifier.urihttps://hdl.handle.net/1805/20959
dc.language.isoen_USen_US
dc.publisherBentham Science Publishersen_US
dc.relation.journalCurrent Cancer Drug Targetsen_US
dc.rightsPublisher Policyen_US
dc.sourcePMCen_US
dc.subjectTesticular canceren_US
dc.subjectGerm cell tumoren_US
dc.subjectEmbryonal carcinomaen_US
dc.subjectCisplatin resistanceen_US
dc.subjectEpigeneticsen_US
dc.subjectDNA methyltransferaseen_US
dc.subjectDecitabineen_US
dc.subjectSGI-110en_US
dc.titleEpigenetic Targeting of Platinum Resistant Testicular Canceren_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
nihms-1007614.pdf
Size:
716.19 KB
Format:
Adobe Portable Document Format
Description:
Main article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: